May 12, 2026   |   Read online Early Coverage: See Why (FEED) Is on Our Screen This Morning Any content you receive is for information purposes only. Always conduct your own research. *Sponsored Daily Edge Report Just ENvue Medical, Inc. (NASDAQ: FEED) at the Top of Its Watchlist for This Morning—Tuesday, May 12, 2026   Don’t miss the next breakout — get real-time alerts sent straight to your phone! Full Coverage Starting Very Soon Take A Look At (FEED) While It’s Still Early… May 12, 2026 Early Coverage: See Why (FEED) Is on Our Screen This Morning Dear Reader, In hospitals, every minute counts. When critically ill patients cannot eat on their own, clinicians often rely on feeding tubes to deliver life-sustaining nutrition and medication. More than 13M feeding tubes are placed each year in the United States, yet an estimated 85% of those procedures are still performed blindly, requiring follow-up X-rays to confirm placement before treatment can begin. ENvue Medical, Inc. (NASDAQ: FEED) is a commercial-stage medical technology company focused on modernizing that process. Its ENvue® system provides clinicians with real-time navigation and bedside confirmation during feeding tube placement, helping improve efficiency, reduce delays, and potentially enhance patient safety. That mission is beginning to gain renewed attention. In just the past few days, (FEED) announced a three-year purchasing agreement renewal with the group purchasing organization for one of the largest nonprofit health systems in the United States. The company also received a new USPTO Notice of Allowance, expanding protection around its proprietary surface acoustic wave (SAW) technology into an additional therapeutic category. Those developments are part of the reason (FEED) has moved to the top of our watchlist this morning—Tuesday, May 12, 2026. The share structure adds another compelling element. With fewer than 900K shares currently available to the public, (FEED) has an exceptionally tight float. When companies with limited share availability begin attracting attention, price movements can become amplified. We have seen this dynamic before. The last time we highlighted (FEED) earlier this year, (FEED) opened near $1.80 on January 28 and reached $3.05 the same day, representing an approximate 69% move in just a few hours, according to Barchart. Two days later, shares traded as high as $6.09, marking an approximate 238% move in less than one week. Past performance does not guarantee future results, but this type of setup tends to draw interest when new catalysts begin to emerge. Beyond the market action, (FEED) has a commercialized product, active hospital deployments, and an expanding intellectual property portfolio. That combination of real-world adoption, new milestones, and a tightly structured float is why (FEED) is one of the most intriguing under-the-radar medical technology stories we are watching ahead of the bell. How (NASDAQ: FEED) Is Bringing Real-Time Navigation to Critical Care (FEED) is a commercial-stage medical technology company focused on improving how hospitals and caregivers deliver enteral nutrition and medication to patients who cannot eat on their own. Headquartered in Tyler, Texas, with research and development operations in Israel, the company is building a platform of intelligent, non-invasive solutions designed to support both hospital and home-based enteral care. At the center of the company’s strategy is the ENvue® Navigation Platform, an FDA 510(k)-cleared system that gives clinicians real-time visual guidance during feeding tube placement. The platform combines a bedside monitor, electromagnetic field generator, and sensor-enabled feeding tubes to help confirm tube positioning without relying solely on blind insertion and repeated X-rays. The goal is to reduce complications, accelerate access to nutrition, and improve workflow efficiency in intensive care and other acute settings. (FEED) is also expanding beyond the hospital setting with its newly launched reusable ENFit® Syringes, over-the-counter enteral syringes designed for feeding and medication delivery in home care and non-acute settings. These products are intended to meet ISO 80369-3 standards and broaden the company’s recurring revenue potentials across the enteral care market. In addition to its enteral care platform, the company maintains two proprietary acoustic-based therapeutic technologies: PainShield® – a wearable device that uses low-intensity surface acoustic wave (SAW) technology for localized pain relief and tissue healing. UroShield® – an ultrasound-based system designed to reduce bacterial colonization and biofilm formation on urinary catheters. With a growing installed base in U.S. hospitals, a commercialized navigation platform, expanding home-care products, and a diversified intellectual property portfolio, ENvue Medical is positioning itself as a specialized medtech company targeting patient safety, hospital efficiency, and long-term recurring revenue. The Massive Market Behind (FEED)’s Technology (FEED) is targeting a large and expanding healthcare market. The global enteral feeding devices market is estimated at approximately $4.97B in 2026 and is projected to grow to $8.98B by 2035, representing a compound annual growth rate (CAGR) of 6.8%. In the United States alone, more than 6M patients depend on enteral feeding each year, with roughly 500,000 gastrostomy tube placements performed annually. North America accounts for approximately 38% of worldwide demand, supported by high healthcare spending, an aging population, and increasing rates of chronic illness. The clinical need is equally significant. According to the company’s April 2026 shareholder letter, pulmonary misplacement, when a feeding tube is unintentionally inserted into the lungs, remains a preventable but potentially life-threatening complication. Traditional blind placement methods can also delay care as clinicians wait for radiology confirmation before feeding begins. (FEED)’s real-time bedside navigation technology is designed to address these challenges by improving patient safety, reducing workflow bottlenecks, and helping hospitals operate more efficiently under growing staffing and cost pressures. Recent Milestones Driving Momentum at (FEED) USPTO Notice of Allowance Expands Intellectual Property Portfolio: ENvue announced that the U.S. Patent and Trademark Office issued a Notice of Allowance covering a novel dr-ug delivery system that uses the company’s proprietary surface acoustic wave (SAW) technology to enhance transdermal delivery of cannabinoid-based therapeutics. Management believes the patent broadens the potential applications of its technology beyond its currently marketed products. Three-Year Purchasing Agreement Renewed Through 2028: The company secured a three-year purchasing agreement renewal with the group purchasing organization (GPO) for one of the largest nonprofit health systems in the United States, serving more than 90 hospitals across 17 states. The agreement extends streamlined purchasing access to ENvue’s products through 2028. 40th U.S. Hospital Customer Added: ENvue announced a new customer win at a 255-bed Virginia medical center affiliated with the Mayo Clinic Care Network, marking the company’s 40th U.S. hospital deployment. This milestone reflects continued adoption of the ENvue Navigation Platform across acute-care settings. Stockholder Letter Highlights Commercial and IP Progress: In its shareholder update, management reported that the ENvue platform had been deployed in 39 U.S. hospitals and emphasized a recurring revenue model driven by single-use feeding tube consumables. The company also highlighted its February patent milestone involving a feeding tube design that combines electromagnetic navigation with a distal-tip camera. Hospital Footprint Expanded to 39 U.S. Hospitals: ENvue announced a new placement within a major Michigan health system, including a 714-bed teaching hospital and Level I Trauma Center. The installation expanded the company’s hospital footprint to 39 sites nationwide. Patent Filed for Camera-Integrated Feeding Tube: The company received a USPTO Notice of Allowance for a feeding tube design that integrates electromagnetic navigation with direct internal visualization through a distal-tip camera, a development management described as a next-generation advancement in guided tube placement. 7 Reasons (FEED) Is at the Top of Our Watchlist for Tuesday, May 12, 2026 Ultra-Low Float Structure: With fewer than 900K shares available to the public, (FEED) has a tightly held share structure that can react sharply when volume and attention increase. Notable Activity: Earlier this year, (FEED) experienced significant volatility, moving from approximately $1.80 to $3.05 during the same session, according to Barchart. Past market activity does not guarantee future results. Extended Follow-Through: Two days later, shares reached $6.09, representing an approximate 238% move in less than one week. Fresh Catalysts: (FEED) recently announced a three-year GPO purchasing agreement renewal and a new USPTO Notice of Allowance expanding its intellectual property portfolio. Expanded Hospital Access: The renewed purchasing agreement provides streamlined access to (FEED)’s products across more than 90 hospitals in 17 states through 2028. Commercial-Stage Platform: The company’s ENvue® Navigation Platform is FDA 510(k)-cleared for adult use and is now deployed across 40 U.S. hospitals. Growing Adoption: (FEED) expanded from 39 U.S. hospitals in March 2026 to 40 hospitals in April 2026, reflecting continued commercial traction and a growing installed base. Get (FEED) On Your Radar While It’s Still Early… The setup taking shape around (FEED) is becoming increasingly difficult to overlook. With fewer than 900K shares available to the public, an FDA 510(k)-cleared platform now deployed across 40 U.S. hospitals, and a renewed purchasing agreement that provides access to more than 90 hospitals in 17 states through 2028, (FEED) appears to be steadily expanding its commercial footprint while still flying under the radar. Layer in two recent USPTO Notices of Allowance, continued growth in hospital adoption, and the sharp momentum the company demonstrated earlier this year, and the story begins to stand out. That combination of a tightly held float, commercial traction, and fresh potential catalysts is why (FEED) has returned to the top of our watchlist heading into Tuesday’s session. We have all eyes on (FEED) this morning.  Take a look at (FEED) while it’s still early. Also, keep a lookout for our next update, it could be out to you within the next 60-90 minutes. Sincerely, Joel Locke Senior Editor Daily Edge Report DailyEdgeReport.com (“DailyEdgeReport” or “DER” ) is owned by GG Media Holdings LLC, a multi member limited liability company. Data is provided from third-party sources and DER is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile DER brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors. ENvue Medical, Inc. (FEED:US) previously changed their company name and symbols from NanoVibronix Inc. (NAOV:US) Pursuant to an agreement between GG Media Holdings LLC and TD Media LLC, GG Media Holdings LLC has been hired for a period beginning on 05/11/2026 and ending on 05/12/2026 to publicly disseminate information about (FEED:US) via digital communications. Under this agreement, TD Media LLC has paid GG Media Holdings LLC seven thousand five hundred USD (“Funds”). These Funds were part of the seventy five thousand USD funds that TD Media LLC received from a third party named Goldwyn Media LLC who did receive the Funds directly or indirectly from the Issuer and does not own stock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices. Neither GG Media Holdings LLC, TD Media LLC and their member own shares of (FEED:US). Please see important disclosure information here: https://dailyedgereport.com/disclosure/feed-UgdqI/#details   Update your email preferences or unsubscribe here © 2026 Daily Edge Report 1401 Pennsylvania Ave Suite 105 Wilmington, Delaware 19806, United States Terms of Service